Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Midodrine and Atomoxetine Treatment in Patients With Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

NCT03350659 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03350659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Midodrine and Atomoxetine Treatment in Patients With Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
March 15, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic orthostatic hypotension